NUR3397: Complex Care A – Medical Science Assignment Help
3–4 minutes
Assignment Task
Brief task description
This assessment requires students to plan, integrate and apply knowledge of safe nursing practice in the management of a patient with a complex metabolic condition in a high acuity setting.
Task detail
This assessment task requires you to choose a complex metabolic condition, then using the Assessment 3 template provided (found under the assessment 3 tab on StudyDesk) provide short answers to the questions below. Need first-class papers? Get Fast Essay Writers US & urgent essay writing service Ca – Note that your answers must be evidence based, written in academic (essay) style and adhere to APA Paper Writing Service by Expert Writers Pro Paper Help: Essay Writing Service Paper Writing Service by Essay Pro Paper Help: Essay Writing Service referencing guidelines.
Identify a complex metabolic condition you have chosen for this assessment. Explain the anatomy and pathophysiology of your chosen complex condition (approximately 200 words).
Identify signs and symptoms of the condition (approximately 150 words).
Determine potential treatment for the condition (approximately 150 words).
Identify potential pharmacological treatments a doctor may order for the condition, including therapeutic indications, mechanism of action, if the drug is safe to use during pregnancy, dosages and methods of administration for each pharmacological treatment. Include in your discussion ethical and legal considerations for administering the pharmacological treatments (approximately 350 words).
Select two (2) medications from the previous question to give to your patient. Provide a narrative script demonstrating how would you educate your patient about the two (2) medications that you are going to administer. Include in your education to the patient contraindications, interactions with other medications and adverse effects. Your narrative script should be in the first person. For example, “Hello my name is …. I am your nurse. I have some medication to give to you…” (approximately 200 words).
Using evidence-based nursing practice, determine nursing management for a patient with the condition (approximately 250 words).
Who will be involved in the patient’s care (approximately 100 words)?
Your patient is ready for discharge. What education and instructions would give to your patient about the condition prior to discharge? Provide a narrative script stating what you would say to your patient (this should be written in the first person) (approximately 100 words).
Include a reference list (as per APA Paper Writing Service by Expert Writers Pro Paper Help: Essay Writing Service Paper Writing Service by Essay Pro Paper Help: Essay Writing Service guidelines).
This NUR3397–Medical Science Assignment
Zabeth Muthee
Identify a complex metabolic condition you have chosen for this assessment. Explain the anatomy and pathophysiology of your chosen complex condition (approximately 200 words).
Identify signs and symptoms of the condition (approximately 150 words).
Determine potential treatment for the condition (approximately 150 words).
Identify potential pharmacological treatments a doctor may order for the condition, including therapeutic indications, mechanism of action, if the drug is safe to use during pregnancy, dosages and methods of administration for each pharmacological treatment. Include in your discussion ethical and legal considerations for administering the pharmacological treatments (approximately 350 words).
Sure, I’d be happy to help. Please let me know the complex metabolic condition that you have chosen for this assessment, and I will provide you with the necessary information.
diabetes mellitus as the complex metabolic condition for this assessment.
Anatomy and Pathophysiology:
Diabetes mellitus is a chronic metabolic disorder characterized by hyperglycemia resulting from defects in insulin secretion, insulin action, or both. Insulin is a hormone produced by the beta cells of the pancreas that regulates the metabolism of glucose, fat, and protein in the body. In diabetes, either the pancreas does not produce enough insulin, or the body’s cells become resistant to the effects of insulin, leading to high levels of glucose in the blood.
Signs and Symptoms:
The signs and symptoms of diabetes mellitus include increased thirst, frequent urination, increased hunger, weight loss, fatigue, blurred vision, slow healing of wounds, and recurrent infections.
Potential Treatment:
The treatment for diabetes mellitus includes lifestyle modifications, such as regular exercise, healthy diet, and weight management, as well as medication management to control blood glucose levels.
Potential Pharmacological Treatments:
Pharmacological treatments for diabetes mellitus may include insulin therapy, oral hypoglycemic agents such as metformin, sulfonylureas, and meglitinides, and injectable GLP-1 receptor agonists such as exenatide and liraglutide.
The therapeutic indications for insulin therapy include hyperglycemia uncontrolled by lifestyle modifications and oral hypoglycemic agents. Insulin works by stimulating glucose uptake and storage in the liver, muscle, and fat cells, thereby reducing the glucose concentration in the blood.
The therapeutic indications for oral hypoglycemic agents vary depending on the drug class. Metformin is the first-line agent for type 2 diabetes and works by decreasing glucose production by the liver and improving insulin sensitivity in the peripheral tissues. Sulfonylureas and meglitinides stimulate insulin secretion from the pancreas.
GLP-1 receptor agonists stimulate insulin secretion, inhibit glucagon secretion, slow gastric emptying, and promote satiety. These agents are indicated for patients with inadequate glycemic control despite maximal doses of oral hypoglycemic agents or insulin therapy.
All of these medications have potential adverse effects, and there are ethical and legal considerations in administering them. For example, insulin can cause hypoglycemia, which can be life-threatening, and must be administered with caution. Oral hypoglycemic agents may cause hypoglycemia or gastrointestinal side effects, and GLP-1 receptor agonists may cause nausea and vomiting. Healthcare providers must monitor patients for these adverse effects and adjust medication regimens as needed. Additionally, healthcare providers must obtain informed consent from patients before administering medications and ensure that they understand the risks and benefits of each medication.
